Abstract -Aims: This study analyzes the reproducibility of the Early Detection of Alcohol Consumption (EDAC) test by sending blood samples obtained from nine volunteers to four different laboratories. It also describes the reproducibility of the EDAC over time by analyzing the results of testing one subject whose blood sample was sent to seven different laboratories over a 10-year period. Methods: The EDAC is a method of interpreting routine laboratory profiles to identify either binge drinking or heavy drinking; the components of the routine panel were chosen based on a best fit predictions model published previously. Results: Overall, the results of the cross-sectional analysis showed that the coefficients of variations (CVs) of the routine tests in the panel were mostly below 16%. Only three analytes (total bilirubin, aspartate aminotransferase and monocytes) showed CVs between 20 and 38%. The differences in the EDAC predictions for these volunteers ranged from 0 to 24%. In the long-term analysis, the variation of the EDAC prediction ranged from 0 to 21% probability of heavy drinking for one subject over time. Thus, mild variations of the EDAC are to be expected when the blood samples are analyzed in different laboratories. However, based on this study, these variations in the prediction of heavy drinking should not exceed >24% when using the EDAC test. Conclusion: This study supports the standard practice established for similar contemporary alcohol biomarkers stipulating that indications of heavy drinking become evident only when subjects experience changes of >30% in the probability of heavy drinking over time.
INTRODUCTION
Several scientific studies (Cargiulo, 2007; Li, 2008; Green et al., 2010) support the notion that heavy drinking is a risk factor for a variety of clinical pathologies and psychosocial problems. Organ damage generally tends to occur after years of active abuse and is manifested through blood tests as abnormalities of lipids, chemistries, liver enzymes and blood counts (Seppä et al., 1992; Montalto and Bean, 2003; Hock et al., 2005) . These abnormalities are captured by the Early Detection of Alcohol Consumption (EDAC) test, a blood test which uses a panel of 20 routine laboratory analytes to provide an objective method to detect heavy drinking (Harasymiw and Bean, 2001a, b; Harasymiw et al., 2004) . For each subject, the results of this panel are then analyzed by linear discriminant function (LDF) analysis to provide categories of alcohol consumption such as light, moderate and heavy drinking. The category of alcohol consumption which best characterizes each subject is then identified, therefore diagnosing the presence or absence of heavy drinking in any given subject.
The EDAC was developed in the 1990s by analyzing the results of routine chemistries, proteins, lipids and blood analytes derived from large populations of subjects, including heavy, light and non-drinkers (Harasymiw and Bean, 2001a, b; Harasymiw et al., 2004) . A summary of several studies (Harasymiw and Bean, 2001a, b; Montalto and Bean, 2003; Harasymiw et al., 2004) shows that the sensitivity of the EDAC to detect alcohol abuse ranges from 66 to 88% in populations of heavy drinkers and the specificity among light and non-drinkers fluctuates around 85-98%, with increasing rates after adjusting the LDF based on gender and age.
The EDAC identifies binge drinking as well as a more chronic consumption of alcohol; most males consuming four standard drinks per day and women consuming three standard drinks daily will show an abnormal EDAC after 2 weeks of drinking. Once the person stops drinking, the EDAC remains elevated for at least 2 weeks and in some individuals it may stay abnormal for more than a month after the start of sobriety making it a valuable test to monitor alcohol abstinence over time .
Since its invention, the EDAC has been used in several clinical and non-clinical populations. For instance, it has been used to screen for alcohol abuse in insurance applicants as well as to monitor abstinence and relapses in several hundred individuals undergoing treatment for alcohol abuse or dependence . It has also been used to detect heavy drinking in young college students of both genders (Harasymiw et al., 2000) and more recently, to identify high-risk repeat intoxicated drivers who continue to drink heavily after their arrest (Bean et al., 2009) . Compared with the traditional liver enzymes, the EDAC identifies heavy drinking in twice as many males and females as the gamma glutamyltransferase (GGT) test (Harasymiw and Bean, 2007) .
Since the EDAC uses a panel of several routine tests to derive a probability of heavy drinking, the question arises as to what is the lab-to-lab variation of the EDAC prediction of heavy drinking when the panel of routine tests is performed in different laboratories. To answer this question, this article analyzes the reproducibility of the EDAC test by testing blood samples obtained from nine adult volunteers tested at four different laboratories. This article also describes the reproducibility of the EDAC over time by analyzing the results of testing the same individual whose blood sample was sent to seven different laboratories over a 10-year period.
METHODS

Study design
Blood samples were obtained from two cohorts of volunteers. The first cohort consisted of four adult volunteers and the second cohort several months later consisted of six volunteers. One of the volunteers (Subject 2) was a member of both cohorts.
The two cohorts of volunteers went to two different sample collection sites where six tubes of blood-three for serum and three for blood counts-were drawn from each. Aliquots of serum and blood from each of the donors were shipped refrigerated to the laboratories mentioned below. The samples from the first cohort (Subjects 1-4) were sent to laboratories 1, 2 and 3, while the samples from the second cohort (Subjects 5-9) were sent to laboratories 1, 2 and 4. The same panel of 19 routine tests was requested from each of the participating laboratories, and the results of these panels were sent to Alcohol Detection Services (ADS, Mukwonago, WI, USA) to perform the LDF analysis.
Participating laboratories
The four laboratories that participated in the reproducibility studies were: 
Subjects
The nine subjects who participated in this study agreed to go to either one of two sample collection sites in Milwaukee County and Dane County (Wisconsin). Subjects 1, 2, 3 and 4 went to the collection site in Milwaukee County, and Subjects 2, 5, 6, 7, 8 and 9 went to the collection site in Dane County. Their histories of alcohol consumption were obtained using the Khavari Alcohol test (Khavari and Farber, 1978) which evaluates the volume and frequency of alcohol consumption for the 30 days before sample collection. Life time histories of alcohol and drug use were also obtained as well as brief medical histories and the current use of prescription/over the counter medications. Subject 1 was a 65 years old healthy Caucasian male who reported a previous history of severe alcoholism followed by 33 recent years of complete sobriety. This subject reported no tobacco or illicit drug use at the time of the samples' collection, was taking a variety of medications to control hypertension and a daily statin to control elevated cholesterol (207 mg/dl).
Subject 2 was a 24 years old healthy Caucasian male, nonsmoker with a medical history of anxiety, depression and allergies who at the time of sample collection was taking 20 mg Prozac daily and a beta blocker to treat his high blood pressure. He reported occasional alcohol consumption of <1-2 drinks per month and no illicit drug use.
Subject 2 volunteered again a few months later as part of cohort no. 2. This time he reported consuming one can of beer, one glass of wine and one shot of liquor 3-4 times per year. He continued to report anxiety and high blood pressure and before sample collection his medication use included Nyquil and a beta blocker.
Subject 3 was a 57 years old healthy Caucasian female who reported a previous history of alcoholism followed by 12 recent years of complete sobriety. Her medical history reports that she underwent hysterectomy in 2005. She reports smoking an average of 10 cigarettes daily and takes 200 mg Wellbutrin every day to help her quit smoking.
Subject 4 was a 55 years old healthy Hispanic female, nonsmoker who reported consumption of 5-7 drinks per week on average. She reports a history of elevated cholesterol and triglycerides in the absence of hypertension. Her medical records show that she underwent surgery for peritonitis in 2004 and she reports no use of prescription or illicit drugs.
Subject 5 was a 34 years old Caucasian male who reported consuming six drinks per week and a shot of whiskey three times per month. He reports no current use of medications and no current medical conditions. He smokes about six cigarettes a month and uses smokeless tobacco on a daily basis.
Subject 6 was a 35 years old Caucasian male, non-smoker who reported drinking ten drinks (beer or wine) within a 1-year period. He is a healthy individual who reports no current medical conditions and no current prescription medication use.
Subject 7 was a 25 years old Caucasian female, nonsmoker who reported consuming six drinks per month on average and one drink of liquor once a year. She reports no current medical conditions and no current prescription medication use.
Subject 8 was a 33 years old Caucasian female, nonsmoker who reported consuming three drinks (wine or beer) 3 or 4 times a week. She also drinks liquor (three drinks) twice a month. Her medical history shows reports of allergies, asthma and idiopathic anaphylaxis, which she treats with cetirizine, ventolin and prednisone. However, no prescription medication use was reported for the month before the blood sample was drawn.
Subject 9 was a 33 years old Caucasian female, nonsmoker who reported consuming 17 cans of beer per year and six glasses of wine each month. Her medical history reveals a broken rib and current medications include percocet.
The EDAC test
The EDAC is a method of interpreting routine laboratory profiles to identify either binge drinking or a more steady daily consumption of alcohol (Harasymiw and Bean, 2001a; Harasymiw et al., 2004) . The components of the routine test panel used in this study are described below; this panel was chosen based on a best fit model reported previously (Harasymiw et al., 2004) . The components of the panel are: Lipids: high density lipoprotein (HDL), cholesterol; Chemistries: phosphorous, chloride, sodium, magnesium, albumin, blood urea nitrogen/creatinine ratio, total bilirubin, direct bilirubin, bilirubin ratio (direct/ indirect), lactate dehydrogenase, alkaline phosphatase, GGT aspartate aminotransferase (AST); Blood analytes: monocytes, hematocrit, platelets and white blood cells.
The method used to calculate the EDAC is called LDF analysis, which is a well-known statistical model of predictions. LDF analysis is useful for situations in which the objective is to build a predictive model of group membership based on observed characteristics of two different samples. In this case, the two different samples were represented by the laboratory parameters of heavy drinkers and light/nondrinkers. The LDF procedure generates a discriminant function based on linear combinations of the predictor variables that provide the best discrimination between the two groups.
Discriminant analysis looks like the right-hand side of a multiple linear regression equation; using coefficients a,b,c,d … x, for the laboratory variables included in the EDAC panel and similar coefficients for gender and age, the function is:
The D value obtained for each subject corresponds to the probability of the subject being a Heavy Drinker ( population 1 ) or a Light/Non Drinker ( population 2 ). The P values represent the probability of the subject being a heavy drinker (P 1 ) or a light drinker/non-drinker (P 2 ). When there is a positive prediction of heavy drinking, the P 1 is in the range of 50-100% and the P 2 is below 50%. In these instances, the individual is classified as a heavy drinker. When P 1 is below 50%, the individual is classified as a light drinker/non-drinker. In addition to probability of drinking, there is also a risk assessment component which determines whether the individual has a low, average or high risk to develop negative consequences related to heavy alcohol consumption.
The EDAC was developed from an extensive database of close to 2000 well-characterized subjects recruited from all across the USA (Harasymiw and Bean, 2001a; Harasymiw et al., 2004) . After development of the LDF equation, the function has been applied to numerous populations and has resulted in several scientific publications starting by Hartz (Hartz et al., 1997) . In general, the EDAC detects >80% of heavy drinkers with <20% false positives in all the populations examined so far.
Reproducibility studies Reproducibility, as defined by the International Conference on Harmonization (ICH, 1996) , represents the precision obtained between different laboratories. The objective is to verify that the method will provide the same results in different laboratories.
The reproducibility of the components of the routine test panel used to calculate the EDAC was determined by analyzing aliquots from the same individual sent to three different laboratories. These laboratories have different analysts and use operational and environmental conditions that may differ from, but are still within the specified parameters of the tests and methods in the panel (inter-laboratory tests). Validation of reproducibility is important if the method is to be used in different laboratories.
In this report, we used the percent coefficients of variation (CV) as a measurement of the reproducibility of the laboratory tests (or process) in the routine panel. The CV is defined as the ratio of the standard deviation (σ) to the mean (µ). The CV is only defined for non-zero means and the absolute value is taken for the mean to ensure it is always positive. In this study, the CV was expressed as percentage by multiplying the results of the ratio by 100. When all other parameters are equal, the lower the CV, the better the test.
Study design
The study design consisted in testing the reproducibility of the EDAC by analyzing the CVs of the replicates of the routine test panel obtained from the nine adult volunteers. The data analysis consisted of both cross-sectional and longitudinal analysis. The cross-sectional analysis consisted in calculating the CVs of the routine tests and comparing the EDAC predictions after testing each of the nine volunteers in three different sites. The longitudinal analysis consisted in comparing the EDAC predictions and the CVs of the routine test panel in Subject 1 who was tested on 11 different occasions in seven different laboratories over a 10-year period (May 1999 -May 2009 .
RESULTS
Cross-sectional reproducibility studies
The first part of this analysis consisted in analyzing the reproducibility of the routine test panels obtained for the nine adult volunteers when each was tested in three different laboratories (Table 1) .
The results of the panel for Subject 1 showed elevated cholesterol (217-224 mg/dl) in all three sites. The chemistry profile showed slightly elevated phosphorus (4.7 mg/dl) at Site 3 and slightly decreased chloride (94-95 mmol/l) at Sites 1 and 3. Lactose Dehydrogenase (LDH) was elevated (194-218 U/l) in all three sites and WBC were elevated (11.0 10 3 /μl) at Site 3. The CVs for the components of the panel were all below 12%. The EDAC predictions showed P-positive values that ranged from 0.002 to 0.004 reflecting a probability of heavy drinking of <1% in the three participating labs (Table 2 ). Based on the EDAC predictions obtained from all three laboratories, this subject was classified as a light drinker. The results of the routine panel for Subject 2 showed elevated cholesterol (209-224 mg/dl) in all three sites. The chemistry profile, liver enzymes and blood counts were all within the normal range in the three sites. The CVs for the components of the panel were all below 13% and the EDAC predictions showed P-positive values ranging from 0.216 to 0.362, representing a probability of heavy drinking in the range of 21.6-36.2% (Table 2 ). This subject shows the highest EDAC predictions of all nine volunteers but the predictions are still within the light drinkers' range which is below 50%.
The results obtained for Subject 2 when tested again a few months later (as part of cohort 2) showed that his cholesterol had normalized and his HDL was low in all three sites (30-33 mg/dl). The only other abnormalities were elevated LDH (211 U/l) at Site 2 and undetectable direct bilirubin (<0.1 mg/dl) at Site 4. The CVs for the components of the routine panel were again below 13% and the EDAC predictions varied from 0.130 to 0.296 representing a probability of heavy drinking in the range of 13-29.6%, consistent with his reports of very occasional drinking.
In Subject 3, the results of the routine panel showed abnormal lipids with elevated HDL cholesterol (62-69 mg/dl) and elevated cholesterol (230-241 mg/dl) at all three sites. The chemistry profile, liver enzymes and the blood counts were all within the normal range. The CVs for most of the components of the panel were below 13% except for total bilirubin and its corresponding bilirubin ratio showing CVs of 25 and 26%, respectively. The EDAC analysis showed a P-positive value which ranged from 0.002 to 0.029 representing a probability of drinking which ranged from 0.2-2.9% in the three different laboratories (Table 2) . Based on the EDAC results, Subject 3 was classified as a light drinker in all three sites.
For Subject 4, the results of the lipid profile showed slightly elevated HDL (63 mg/dl) at Site 2 and elevated cholesterol (218-231 mg/dl) at all three sites. The chemistry profile, liver enzymes and the blood counts were within the reference ranges in all three sites. The CVs for the routine panel were all below 13% (Table 1) , and the EDAC predictions showed a P-positive value of 0.001 in all three sites representing a probability of heavy drinking of <1% (Table 2 ). In addition, these results showed that consumption of 5-7 drinks per week as reported by this individual does not cause a positive EDAC test result.
For Subject 5, the only abnormality reported was high HDL in Sites 2 and 4 (62 and 69 mg/dl, respectively). The chemistry profile, liver enzymes and blood counts were within the reference ranges in all three sites. The CVs were all below 15% (Table 1 ) and the EDAC predictions showed a P-positive value ranging from 0.019 to 0.085 representing a probability of heavy drinking of <10% in all three sites (Table 2 ). This subject was classified as a light drinker which is consistent with his reports of consuming six drinks per week.
For Subject 6, the results of the lipid panel showed elevated HDL cholesterol (64 mg/dl) at Sites 2 and 4 and elevated cholesterol (227-240 mg/dl) in all three sites. The chemistry profile showed elevated LDH (198 U/l) at Site 2 and low sodium (132 mmol/l) and low direct bilirubin (<0.1 mg/dl) at Site 4; the blood panel was within the reference range in all three sites. The CVs for the routine tests of the panel were mostly below 11% except for total bilirubin (20%), AST (22%) and monocytes (38%). The EDAC predictions showed a P-positive value ranging from 0.018 to 0.147, representing a probability of heavy drinking of <15% in all three sites (Table 2 ). This subject was classified as a light drinker which is also consistent with his reports of drinking 10 drinks per year.
For Subject 7, the only abnormality reported was low sodium (132 mmol/l) and low direct bilirubin (<0.1 mg/dl) at Site 4. The lipid profile, liver enzymes and the blood counts were within the reference ranges in all three sites. The CVs were all <14% except for total bilirubin, which was 21%. The EDAC predictions showed a P-positive value ranging from 0.024 to 0.209, representing a probability of heavy drinking ranging from 2 to 21% (Table 2 ). This subject was classified as a light drinker which is consistent with her reports of consuming only six drinks per month.
For Subject 8, the only abnormality reported was low sodium (131 mmol/L) and low direct bilirubin (<0.1 mg/dl) at Site 4. The lipid profile, liver enzymes and the blood counts were within the reference ranges in all three sites. The CVs for the routine panel components were all below 14% except for AST with a CV of 22% and total bilirubin with a CV of 29%. The EDAC predictions showed a P-positive value ranging from 0.029 to 0.271 representing a probability of heavy drinking ranging from 3 to 27% in all three sites (Table 2 ). This subject is a light drinker consistent with her reports of drinking 3 drinks of wine or beer 3-4 times per week. %P-pos = probability of heavy drinking.
For Subject 9, the only abnormality reported was low direct bilirubin (<0.1 mg/dl) at Site 4. The lipid profile, liver enzymes and the blood counts were within the reference ranges in all three sites. The CVs for the routine analytes were all below 16% except for total bilirubin with a CV of 20% and monocytes with a CV of 32%. The EDAC predictions for Subject 9 showed a P-positive value ranging from 0.020 to 0.046, representing a probability of heavy drinking of <4.6% at all three sites (Table 2 ). This subject was classified as a light drinker which is consistent with her reports of consuming six glasses of wine per month.
Longitudinal reproducibility study
The longitudinal studies for the EDAC analysis were conducted with blood samples obtained from Subject 1 over a 10-year period using seven different laboratories (Table 3) . Several components of the routine panel showed results consistently within the normal range for all sites. These components were: magnesium, albumin, BUN/creatinine ratio, total bilirubin, bilirubin ratio, alkaline phosphatase, GGT, AST, hematocrit and platelets.
Other components of the routine panel showed some variability. For instance, the lipid profile showed HDL cholesterol was low (36 mg/dl) only at Draw no. 7, whereas cholesterol was elevated at Draws no. 1, 3, 4, 5, 6, 8 and 10 (200-262 mg/dl) . The protein chemistry profile showed elevated phosphate level at Draws no. 2 and 4 (4.6-4.7 mg/dl) and a low chloride level (94 mmol/l) at Draw no. 1. Direct bilirubin was elevated at Draws no. 2 and 6 (0.29-0.4 mg/dl) and LDH was elevated at Draws no. 1, 2 and 3 (194-258 U/l). The blood profile WBC was elevated only at Draw no. 4.
In terms of CV, half the analytes in the panel showed a CV <20% and half had a CV >20%. Total and direct bilirubin were the only two components of the panel with CVs >30%. Despite these CVs, the EDAC predictions show minimal variability over 10 years except for one instance where the P-positive value was 0.21 at Draw no. 6. This 0.21 value can be explained by the type and the number of abnormalities which occurred simultaneously on this draw.
DISCUSSION
Several previous studies (Ryback et al., 1980 (Ryback et al., , 1982 Hawkins et al., 1984; Vanclay et al., 1991; Hartz et al., 1997) have reported the use of a discriminant function analysis based on a number of biochemical and haematological tests to identify heavy drinkers in community screening and clinical populations of various kinds. In general, these studies report that a combination of routine blood chemistry variables can predict the probability of heavy drinking in any given subject with a high degree of accuracy. However, none of these studies have reported the lab-to-lab variability of the routine tests components of these panels or the variability of the linear discriminant analysis technique in classifying subjects as light or heavy drinkers. To share some knowledge in this area, the purpose of this study was to measure the variability for one of these LDF techniques called the EDAC test between sites and over time.
Overall, the results of the cross-sectional analysis in the nine volunteers show that the reproducibility of the analytes-measured as CV-was <16% for most components of the panel except for total bilirubin, AST and monocytes. Briefly, five of the nine volunteers (Subjects 3, 6, 7, 8 and 9) show variations of total bilirubin ranging from 20 to 29%, two volunteers (Subjects 6 and 8) showed variations of AST equal to 22% and two volunteers (Subjects 6 and 9) show variations in monocytes equivalent to 32 and 38%. Wide variations in monocytes are not surprising because several common conditions such as mild infections and allergies can cause increases in monocytes. Therefore, to avoid major changes in the predictions of heavy drinking due to the effects of variations in monocytes the EDAC analysis caps monocytes at 8% for males and females under the age of 40. In addition, the CVs for direct bilirubin (and bilirubin ration, which is the ratio of direct over total bilirubin) in Subjects 5-9 could not be calculated because the values reported by Site 4 were below the limit of detection (<0.1 mg/dl) for this analyte. The EDAC predictions for these subjects were calculated using a value of zero for direct bilirubin. The variations in the percentages of the EDAC predictions for these nine subjects ranged from 0% in Subject 4 to 24% in Subject 8. Thus, Subject 4 showed a 0.1% probability of heavy drinking in all three sites for an overall variation of 0% (0.1 − 0.1% = 0%), and Subject 8 showed the smallest (3%) probability of heavy drinking in Site 1 and the largest (27%) probability of heavy drinking in Site 4 for an overall variation of 24% (27 − 3 = 24%). Subject 6, 7 and 8-who showed the largest variations in the EDAC percentages across sites (13, 18 and 24%, respectively)-also show some of the largest CVs for total bilirubin, AST and monocytes. Not surprisingly, bilirubin, AST and monocytes are among the top seven variables impacting the EDAC predictions in stepwise analysis (Harasymiw et al., 2004) . Mild variations of the EDAC are also expected based on gender and age (Harasymiw and Bean, 2001a) .
Overall, these variations of the percentages of the EDAC analysis among all nine subjects tested suggest that the reproducibility of the EDAC can vary up to 24% for each individual among different laboratories. In fact, mild variations of the EDAC are to be expected when the blood samples are analyzed in different laboratories. Typical variations affecting a method's reproducibility are:
• Differences in room temperature and humidity Despite these variations, the EDAC predictions produced consistent results for each individual across several laboratories.
In the long-term analysis, the variation of the EDAC prediction ranged from 0 to 21% probability of heavy drinking for one subject over time. This long-term variation in the EDAC predictions for Subject 1 is consistent with his mild pattern of abnormalities in the components of the routine panel and his reports of no alcohol consumption for the 30 days prior to the sample collection which was verified by collateral reports. Variations of the LDF that fluctuate around 20% are deemed low considering that they represent the sum of various parameters.
Based on this study, variations in the prediction of heavy drinking should not exceed >24% for any given subject reporting light drinking or no drinking. Therefore, predictions of heavy drinking become evident only when the subject been tested experiences changes of >30% in the probability of heavy drinking over time. Thus, a 30 points increase from an abstinent baseline indicates a relapse to heavy drinking and a 30 points decrease from a drinking baseline represents a period of reduced drinking or abstinence. These values are similar to the standard interpretations of abstinence and relapses used for the carbohydrate-deficient transferrin test (Anton et al., 1996) .
There are three features of the EDAC that make it especially suitable for use in both clinical and non-clinical settings. The most obvious is that the EDAC is an interpretive test, which is derived from routine blood tests that are typically performed for other clinically valid purposes. All the laboratory tests in this list are FDA approved and reimbursement for the EDAC test can be obtained by using specific Current Procedural Terminology codes. For patients with elevated EDAC results, the physician can objectively discuss risk factors associated with consuming excessive quantities of alcohol in the same manner as discussing an elevated lipid ratio as a risk factor for cardiovascular disease. Based of this study, the site-to-site variability of the EDAC analysis is similar to the variability currently accepted as standard for routine laboratory variables.
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